X
Record #7354

Structure-based development and optimization of therapy antibody drugs against TNFa

Publisher
Springer
Original paper date
Mar 14, 2015
Institution
Key Laboratory of Oncology, Cancer Center, Chinese PLA General Hospital and Chinese PLA Medical School, Beijing, People’s Republic of China · Translational Medicine Research Institute and International Joint Cancer Institute, The Second Military Medical University, Shanghai, People’s Republic of China · Tianjin Joint Academy of Biomedicine and Technology, Tianjin, People’s Republic of China · Graduate School of Medicine, Nagoya University, Nagoya, Japan · School of Medicine, Nankai University, Tianjin, People’s Republic of China · Department of Biomedicine, Nagoya University, Nagoya, Japan · Laboratory of Structural Biology and MOE Laboratory of Protein Science, School of Medicine, Tsinghua University, Beijing, People’s Republic of China · Molecular Drug Discovery Center, Xi’an Jinwa Pharmaceutical Co., Ltd, Xi’an, People’s Republic of China
Open access
No
Article type
Research Article
Broad categories
(BLS) Genetics(HSC) Medicine - Drug Design(HSC) Medicine - Immunology(HSC) Medicine - Infectious Disease
Citation lifecycle

How this paper is being cited

Pre-retraction
0
Same day
1
Post-retraction
0
% post-retraction
0.0%
~0.0 citations/yr before retraction · ~0.0 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse